Cargando…
Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents?
BACKGROUND: Hypercalciuria is the most common metabolic risk factor for calcium urolithiasis and is associated with bone loss in adult patients. Reduced bone mineral density (BMD) was already described in idiopathic hypercalciuria (IH) children, but the precise mechanisms of bone loss or inadequate...
Autores principales: | Penido, Maria Goretti Moreira Guimarães, Tavares, Marcelo de Sousa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353600/ https://www.ncbi.nlm.nih.gov/pubmed/34430384 http://dx.doi.org/10.5527/wjn.v10.i4.47 |
Ejemplares similares
-
Role of FGF23 in Pediatric Hypercalciuria
por: Moreira Guimarães Penido, Maria Goretti, et al.
Publicado: (2017) -
Beyond kidney stones: Why pediatricians should worry about hypercalciuria
por: Penido, Maria Goretti Moreira Guimarães, et al.
Publicado: (2021) -
Prevalence of risk factors for cardiovascular and kidney disease in Brazilian healthy preschool children
por: da Silva, Adriana Cândida, et al.
Publicado: (2016) -
Para-aortic lymph node involvement should not be a contraindication to resection of pancreatic ductal adenocarcinoma
por: Pande, Rupaly, et al.
Publicado: (2022) -
Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
por: Tian, Ci, et al.
Publicado: (2021)